Heimdall Insights

Global Multiple Sclerosis Therapeutics Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: July 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Multiple Sclerosis Therapeutics Market was valued at $30.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.2% CAGR, to an estimated market size of $38.7 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global Multiple Sclerosis (MS) therapeutics market includes disease-modifying therapies (DMTs), monoclonal antibodies, and symptomatic treatments designed to manage the chronic autoimmune disorder of the central nervous system.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Multiple Sclerosis Therapeutics Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Oral Therapies
  • Injectable Therapies
  • Infusion Therapies